Levemir 100 UNT/ML 3 ML FlexTouch
- RxCUI
- 847241
- RxNorm name
- Levemir 100 UNT/ML 3 ML FlexTouch
- Display name
- Levemir 100 UNT/ML 3 ML FlexTouch
- Full name
- Levemir 100 UNT/ML 3 ML FlexTouch
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:22
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 021536 | Levemir | insulin detemir | 351(a) | Disc | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levemir | INSULIN DETEMIR | A-S Medication Solutions | 82192527-99aa-4b53-8ce9-9173668d309c | 2024-10-09 | Warnings, Adverse reactions | 847241 |
| Levemir | INSULIN DETEMIR | Novo Nordisk | d38d65c1-25bf-401d-9c7e-a2c3222da8af | 2022-12-08 | Warnings, Adverse reactions | 847241 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| d38d65c1-25bf-401d-9c7e-a2c3222da8af | Levemir 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin detemir 100 UNT/ML Pen Injector [Levemir] [SBD] · 3 ML Levemir 100 UNT/ML Pen Injector [SY] · Levemir 100 UNT/ML 3 ML FlexPen [SY] · Levemir 100 UNT/ML 3 ML FlexTouch [SY] · Levemir 100 UNT/ML 3 ML PenFill [SY] | 6 | 30 | These highlights do not include all the information needed to use LEVEMIR ® safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR ® (insulin detemir) injection, for subcutaneous use Initial U.S. Approval: 2005 | 20221208 |
| 82192527-99aa-4b53-8ce9-9173668d309c | Levemir 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin detemir 100 UNT/ML Pen Injector [Levemir] [SBD] · 3 ML Levemir 100 UNT/ML Pen Injector [SY] · Levemir 100 UNT/ML 3 ML FlexPen [SY] · Levemir 100 UNT/ML 3 ML FlexTouch [SY] · Levemir 100 UNT/ML 3 ML PenFill [SY] | 6 | 24 | These highlights do not include all the information needed to use LEVEMIR ® safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR ® (insulin detemir) injection, for subcutaneous use Initial U.S. Approval: 2005 | 20241009 |
| 9dc15d2d-e707-4014-9834-e202e8fc3089 | Levemir 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin detemir 100 UNT/ML Pen Injector [Levemir] [SBD] · 3 ML Levemir 100 UNT/ML Pen Injector [SY] · Levemir 100 UNT/ML 3 ML FlexPen [SY] · Levemir 100 UNT/ML 3 ML FlexTouch [SY] · Levemir 100 UNT/ML 3 ML PenFill [SY] | 6 | 24 | These highlights do not include all the information needed to use LEVEMIR ® safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR ® (insulin detemir) injection, for subcutaneous use Initial U.S. Approval: 2005 | 20230503 |
| 35e31793-9df4-4773-82b2-59678d8652bf | Levemir 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin detemir 100 UNT/ML Pen Injector [Levemir] [SBD] · 3 ML Levemir 100 UNT/ML Pen Injector [SY] · Levemir 100 UNT/ML 3 ML FlexPen [SY] · Levemir 100 UNT/ML 3 ML FlexTouch [SY] · Levemir 100 UNT/ML 3 ML PenFill [SY] | 6 | 24 | These highlights do not include all the information needed to use LEVEMIR ® safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR ® (insulin detemir) injection, for subcutaneous use Initial U.S. Approval: 2005 | 20230312 |
| eae6fcac-02a9-4d7c-8445-03a647b6b59b | Levemir 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin detemir 100 UNT/ML Pen Injector [Levemir] [SBD] · 3 ML Levemir 100 UNT/ML Pen Injector [SY] · Levemir 100 UNT/ML 3 ML FlexPen [SY] · Levemir 100 UNT/ML 3 ML FlexTouch [SY] · Levemir 100 UNT/ML 3 ML PenFill [SY] | 6 | 2 | These highlights do not include all the information needed to use LEVEMIR ® safely and effectively. See full prescribing information for LEVEMIR. LEVEMIR ® (insulin detemir [rDNA origin] injection) solution for subcutaneous injection Initial U.S. Approval: 2005 | 20120302 |